Brief S2k guidelines - Basal cell carcinoma of the skin;S2k Kurzleitlinie - Basalzellkarzinom der Haut

JDDG - Journal of the German Society of Dermatology

Volumn 11, Issue SUPPL. 3, 2013, Pages 10-15

  Hauschild, Axel ^a   Breuninger, Helmut ^b   Kaufmann, Roland ^c   DieterKortmann, Rolf ^d   Klein, Martin ^e   Werner, Jochen ^f   Reifenberger, Julia ^g   Dirschka, Thomas ^h   Garbe, Claus ^b  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^c UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^d Department of Radiation Therapy and Radio oncology ^*  (Germany)

^e Fachklinik Hornheide   (Germany)

^f UNIVERSITY HOSPITAL MARBURG   (Germany)

^g HEINRICH HEINE UNIVERSITY   (Germany)

^h Dermatology Practice   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; IMIQUIMOD; SONIC HEDGEHOG PROTEIN; SONIDEGIB; VISMODEGIB;

ARTICLE; BASAL CELL CARCINOMA; BASAL CELL NEVUS SYNDROME; CANCER CHEMOTHERAPY; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER SURGERY; CONFLICT OF INTEREST; CRYOTHERAPY; DIFFERENTIAL DIAGNOSIS; EPILUMINESCENCE MICROSCOPY; EXCISION; FOLLOW UP; HEREDITY; HISTOPATHOLOGY; HUMAN; LOW LEVEL LASER THERAPY; MULTIMODALITY CANCER THERAPY; PHOTODYNAMIC THERAPY; PRACTICE GUIDELINE; PSYCHOSOCIAL DISORDER; SECONDARY PREVENTION; SIGNAL TRANSDUCTION; SKIN METASTASIS; TUMOR VOLUME;

CARCINOMA, BASAL CELL; DERMATOLOGY; GERMANY; HUMANS; MEDICAL ONCOLOGY; PRACTICE GUIDELINES AS TOPIC; SKIN NEOPLASMS;

EID: 84876239948     PISSN: 16100379     EISSN: 16100387     Source Type: Journal    
DOI: 10.1111/ddg.12015_3     Document Type: Article

References (18)

1. Gilbody JS, Aitken J, Green A. What causes basal cell carcinoma to be the commonest cancer? Aust J Public Health 1994; 18: 218-21.
2. Miller DL, Weinstock MA. Nonmelanoma skin cancer in the United States: incidence. J Am Acad Dermatol 1994; 30: 774-8.
3. Telfer NR, Colver GB, Morton CA. Guidelines for the management of basal cell carcinoma. Br J Dermatol 2008; 159: 35-48.
4. Felder S, Rabinovitz H, Oliviero M, Kopf A. Dermoscopic differentiation of a superficial basal cell carcinoma and squamous cell carcinoma in situ. Dermatol Surg 2006; 32: 423-5.
5. Costantino D, Lowe L, Brown DL. Basosquamous carcinoma - an underrecognized, high-risk cutaneous neoplasm: case study and review of the literature. J Plast Reconstr Aesthet Surg 2006; 59: 424-8.
6. Löser C, Rompel R, Möhrle M, Häfner HM, Kunte C, Hassel J, Hohenleutner U, Podda M, Sebastian G, Hafner J, Konz B, Kaufmann R, Breuninger H. Microscopically controlled surgery (MCS). J Dtsch Dermatol Ges 2010; 8: 920-5.
7. Rowe DE, Carroll RJ, Day CL. Mohs surgery ist he treatment of choice for recurrent (previously treated) basal cell carcinoma. J Dermatol Surg Oncol 1989; 15: 424-31.
8. Rowe DE, Carroll RJ, Day CL Jr et al. Long-term recurrence rates in previously untreated (primary) basal cell carcinoma: implications for patient follow-up. J Dermatol Surg Oncol 1989; 15: 315-28.
9. Caccialanza M, Piccinno R, Grammatica A. Radiotherapy of recurrent basal and squamous cell skin carcinomas: a study of 249 re-treated carcinomas in 229 patients. Eur J Dermatol 2001; 11: 25-8.
10. Finizio L, Vidali C, Calacione R et al. What is the current role of radiation therapy in the treatment of skin carcinomas? Tumori 2002; 88: 48-52.
11. Kuflik EG. Cryosurgery for skin cancer: 30-year experience and cure rates. Dermatol Surg 2004; 30: 297-300.
12. Wang I, Bendsoe N, Klinteberg CA et al. Photodynamic therapy vs. cryosurgery of basal cell carcinomas: results of a phase III clinical trial. Br J Dermatol 2001; 144: 832-40.
13. Marks R, Gebauer K, Shumack S et al. Imiquimod 5% cream in the treatment of superficial basal cell carcinoma: results of a multicenter 6-week dose-response trial. J Am Acad Dermatol 2001; 44: 807-13.
14. Geisse JK, Rich P, Pandya A et al. Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: a double-blind, randomized, vehiclecontrolled study. J Am Acad Dermatol 2002; 47: 390-8.
15. Geisse J, Caro I, Lindholm J et al. Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from two phase III, randomized, vehicle-controlled studies. J Am Acad Dermatol 2004; 50: 722-33.
16. von Hoff DD, LoRusso PM, Rudin CM et al. Inhibition of the hedgehog pathway in advanced basal-cell carcinoma. N Engl J Med 2009; 361: 1164-72.
17. Holfeld KI, Hogan DJ, Eldemire M, Lane PR. A psychosocial assessment of patients with basal cell carcinoma. J Dermatol Surg Oncol 1990; 16: 750-3.
18. Shah M, Mavers M, Bree A, Fosko S, Lents NH. Quality of life and depression assessment in nevoid basal cell carcinoma syndrome. Int J Dermatol 2011; 50: 268-76.